A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (Q63807743)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide |
clinical trial |
Statements
OCEAN (English)
0 references
A Randomized, Controlled, Open-label, Phase 3 Study of Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone for Patients With Relapsed Refractory Multiple Myeloma Who Are Refractory to Lenalidomide (English)
0 references
13 June 2017
0 references
December 2019
0 references
450
0 references
18 year
0 references